Medtronic Remains Aggressive In Diabetes Market, Obtains Two CE Marks
Executive Summary
To increase its diabetes care products market share, Medtronic has obtained CE marks for a new continuous glucose monitor and a smart insulin pen.
You may also be interested in...
Digital Health Roundup, May 2021: Immersive Technologies In Surgery Suite, ‘Smart’ Toilets And Pills; New SaMD Cybersecurity Standards
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from May.
ATTD 2021: Despite High Upfront Cost, Medtronic’s 780G Could Offer Cost Savings
In a talk at the 2021 Advanced Technologies & Treatments for Diabetes conference, Medtronic's European director of medical affairs explained how its MiniMed 780G insulin pump can reduce long-term treatment costs for diabetics.
Market Intel: Rivalry Among Insulin Pump Makers Heats Up With Expected Launches In 2021
The global insulin pump market is expected to see double-digit growth, reaching $5.1bn in 2024, with product launches expected by Medtronic, Insulet, Tandem and smaller players in 2021.